ASHLEY SHEPARD: Open Payments
NPI 1982428140 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $94 |
| Axsome Therapeutics, Inc. | 1 | $94 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Lundbeck LLC | 2 | $36 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: Auvelity, REXULTI, INVEGA SUSTENNA, AUSTEDO XR, SPRAVATO, INGREZZA, ABILIFY MAINTENA, Jornay PM.
Industry payments across AR — which companies pay providers there.
